Impact of gastrointestinal disease states on oral drug absorption – implications for formulation design – a PEARRL review
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Pharmacy and Pharmacology"
DOI: 10.1111/jphp.12928
Abstract: Drug product performance in patients with gastrointestinal (GI) diseases can be altered compared to healthy subjects due to pathophysiological changes. In this review, relevant differences in patients with inflammatory bowel diseases, coeliac disease, irritable bowel… read more here.
Keywords: states oral; impact gastrointestinal; gastrointestinal disease; disease ... See more keywords